Presence of herpesviruse DNA in lymphocytes isolated from patients with blood disorders

• Autorzy: Zuk-Wasek A. , Litwinska B. , Traczyk Z.
• Języki publikacji: EN

Abstrakty

EN

The aim of this study was to check the presence of DNA of five human herpesviruses in lymphocytes isolated from peripheral blood of people with lymphoproliferative diseases and to investigate the relationship between these disorders and the presence of the viruses. A total of 113 blood specimens from patients with different blood disorders and 96 specimens from healthy people (control group) were obtained. Among 113 specimens from patients with blood disorders, DNA of EBV in 39.8%, CMV in 30.1%, HHV6 in 8.0%, HHV7 in 20.4%, and HHV8 in 9.7% of the people was detected. Among 96 specimens from healthy people, DNA of EBV was detected in 9.3%, CMV in 27.1%, HHV6 in 4.2%, HHV7 in 13.5%, and HHV8 in 4.2%. It was found that the differences in presence and number of viruses between groups were very significant. Significantly, a larger detection of DNA of EBV in blood disorder group was observed. These results suggest the participation of EBV in blood disorders.

• Wydawca: -
• Czasopismo: Bulletin of the Veterinary Institute in Puławy
• Rocznik: 2008
• Tom: 52
• Numer: 4
• Opis fizyczny: p.511-515,fig.,ref.

Twórcy

autor

Zuk-Wasek A.

• Department of Virology, National Institute of Public Health - National Institute of Hygiene, 00-791 Warsaw, Poland

autor

Litwinska B.

• Department of Virology, National Institute of Public Health - National Institute of Hygiene, 00-791 Warsaw, Poland

autor

Traczyk Z.

• Department of Internal Diseases, Institute of Haematology and Transfusiology, 02-776 Warsaw, Poland

Bibliografia

• 1. Akiba S., Koriyama C., Herrera- Goepfert R., Eizuru Y.: Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features. Cancer Sci 2008, 99, 195-201.
• 2. Alves G., Marcini C.M., de Suoza Nascimento P., Morais J.C., Ornellas A.A.: Detection and expression of Epstein- Barr virus (EBV) DNA in tissues from penile tumors in Brazil. Cancer Lett 2004, 215, 79-82.
• 3. Boshoff C., Chang Y.: Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus. Annu Rev Med 2001, 52, 453-470.
• 4. Cathomas G.: Kaposi's sarcoma-associated Herpesvirus (KSHV)/Human Herpesvirus 8 (HHV-8) as a tumour virus. Herpes 2003, 10, 72-77.
• 5. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., Moore P.S.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266, 1865-1869.
• 6. Cohen J.L.: Epstein-Barr virus infection. N Engl J Med 2000, 34, 481-492.
• 7. Cuconati A., Mukherjee C., Perez D., White E.: Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev 2003, 16, 2465-2478.
• 8. Deshpande C.G., Badve S., Kidwai N., Longnecker R.: Lack of expression of the Epstein-Barr virus (EBV) gene products, EBERs, EBNA1, LMP1 and LMP2, in breast cancer cells. Lab Invest 2002, 82, 1193-1199.
• 9. Ferrazzo K.L., Mesquita R.A., Aburat A.T., Nunes F.D., de Sousa S.O.: EBV detection in HIV-related oral plasmablastic lymphoma. Oral Dis 2007, 13, 564- 569.
• 10. Fiorini S., Ooka T.: Secretion of Epstein-Barr virus encoded BARF1 oncoprotein from latently infected B cells. J Virol 2008, 5, 1-4.
• 11. Hsu J.L., Glosen S.L.: Epstein-Barr virus-associated malignancies: epidemiologic patterns and ethiologic implication. Crit Rev Oncol Hematol 2000, 34, 27-53.
• 12. Imai S., Koizumi S., Sugiura M., Tokunaga M., Uemura Y., Yamamoto N., Tanaka S., Sato E., Osato T.: Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 1994, 91, 9131-9135.
• 13. Iwatsuki K., Yamamoto T., Tsuji K., Suzuki D., Fujii K., Matsuura H., Oono T.: A spectrum of clinical manifestations caused by host immune responses against Epstein-Barr virus infections. Acta Med Okayama 2004, 58, 169-180.
• 14. Kaye M.K., Izumi K.M., Kieff E.: Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1993, 90, 9150-9154.
• 15. Li H.-P., Chang Y.-S.: Epstein-Barr virus latent membrane protein 1: structure and functions. J Biomed Sci 2003, 10, 490-504.
• 16. Luo B., Wang Y., Wang X.F., Liang H., Yan L.P., Huang B.H., Zhao P.: Expression of Epstein-Barr virus genes in EBV associated gastric carcinomas. World J Gastroenterol 2005, 11, 629-633.
• 17. Malinowska I.: The role of apoptosis in the pathogenesis and treatment of neoplastic disorders of the hematopoietic system. Postępy Hig Med Dosw 2004, 58, 548-559.
• 18. Niedobitek G., Agathenggelon A., Herbst H., Whitehead L., Wright D.H., Young L.S.: Epstein-Barr virus (EBV) infection in infectious mononucleosis: virus latency replication and phenotype of EBV-infected cells. J Pathol 1997, 182, 151-159.
• 19. Oda K., Tamara J., Takenouchi T., Mikata A., Nunomura M., Saitoh N., Sarashina H., Nakajima N.: Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol 1993, 143, 1063-1071.
• 20. Parsonnet J.: Infection and cancer: Viruses In: Microbes and malignancy. Oxford University Press, New York, Oxford, 1999, pp. 157-312
• 21. Perrigoue J.G., den Boon J.A., Friedl A., Newton M.A., Ahlquist P., Sugden B.: Lack of association between EBV and breast carcinoma. Cancer Epidemiol Biomarkers Prev 2005, 14, 809-814.
• 22. Pozo F., Tenorio A.: Detection and typing of lymphotropic herpesviruses by multiplex polymerase chain reaction. J Virol Methods 1999, 79, 9-19.
• 23. Queiroga E.M., Gualco G., Chioato L., Harrington W.J., Araujo I., Weiss L.M., Bacchi C.E.: Viral studies in Burkitt lymphoma: association with Epstein-Barr virus but not HHV8. Am J Clin Pathol 2008, 130, 186-192.
• 24. Reed J.C.: Dysregulation of apoptosis in cancer. J Clin Oncol 1999, 17, 2941-2953.
• 25. Rickinson A.B., Kieff E.: Epstein-Barr virus. In: Field's Virology. Editors Lippincott Williams & Wilkins, Philadelphia, 2001, Chapter 74, pp. 2397-2446.
• 26. Sarmati L.: Serological testing for human herpesvirus 8. Herpes 2001, 8, 76-79.
• 27. Shair K.H.Y., Bendt K.M., Edwards R.H., Bedford E.C., Nielsen J.N., Raab-Traub N.: EBV latent membrane protein activates Akt, NFκB and Stat3 in B cell lymphomas. PLoS Pathogens 2007, 3, 1669-1683.
• 28. Teodoro J.G., Branton P.E.: Regulation of apoptosis by viral gene products. J Virol 1997, 71, 1739-1746.
• 29. Thompson M.P., Kurzrock R.: Epstein-Barr virus and cancer. Clin Cancer Res 2004, 10, 803-821.
• 30. Wang Y., Luo B., Yan L.P., Huang B.H., Zhao P.: Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis and apoptosis- related proteins in gastric carcinoma. World J Gastroenerol 2005, 11, 3234-3239.
• 31. Zheng H., Li L., Hu D., Deng X., Cao Y.: Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol 2007, 4, 185-196.
• 32. Zur Hausen A., Brink A.A., Craanen M.E., Middlerop J.M., Meijer C.J., van der Brule A.J.: Unique transcription pattern of Epstein-Barr virus (EBV) in EBV carrying gastric carcinomas: expression of transforming BARF1 gene. Cancer Res 2000, 60, 2745-2748.